TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 30247753

Group type: EXPERIMENTAL
Intervention: Adaptive WM training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Active control training
Number of subjects: 0
Study: 27604571

Group type: EXPERIMENTAL
Intervention: Knowledge translation intervention employing educational outreach, a point-of-care reminder tool, and a peer support network
Number of subjects: 600

Group type: COMPARATOR
Intervention: Standard lay health worker training
Number of subjects: 600
Study: 24406723

Group type: EXPERIMENTAL
Intervention: Intranasal orexin-A (435 nmol)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Sterile water (placebo)
Number of subjects: 14
Study: 22512266

Group type: EXPERIMENTAL
Intervention: Calibration(PRE)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Calibration(POST)
Number of subjects: 20
Study: 19894018

Group type: EXPERIMENTAL
Intervention: GSA scintigraphy (HH15 and LHL15) after partial hepatic resection (Hr0)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: GSA scintigraphy (HH15 and LHL15) after sectionectomy (Hr1)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: GSA scintigraphy (HH15 and LHL15) after bisectionectomy (Hr2)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Hematobiochemical tests and remnant liver volume monitoring
Number of subjects: 86
Study: 18308816

Group type: EXPERIMENTAL
Intervention: Clozapine treatment
Number of subjects: 26

Group type: COMPARATOR
Intervention: Unmedicated persons with schizophrenia
Number of subjects: 26

Group type: COMPARATOR
Intervention: Healthy subjects
Number of subjects: 26
Study: 16282050

Group type: EXPERIMENTAL
Intervention: Chinese herbal drug therapy (glucosidorum Tripterygii totorum tablets and Yishen Juanbi Tablets)
Number of subjects: 413

Group type: COMPARATOR
Intervention: Western medicine therapy (voltaren extended release tablets, methotrexate, and sulfasalazine)
Number of subjects: 413
Study: 12903698

Group type: EXPERIMENTAL
Intervention: Hydrogel dressings
Number of subjects: 106

Group type: COMPARATOR
Intervention: Lanolin ointment
Number of subjects: 106
Study: 10507103

Group type: EXPERIMENTAL
Intervention: Partial hospitalization rehabilitation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Inpatient rehabilitation
Number of subjects: 0
Study: 7851599

Group type: EXPERIMENTAL
Intervention: Semen samples from men with spinal cord injury
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Percoll‐washed spermatozoa from men with spinal cord injury
Number of subjects: 0

Group type: COMPARATOR
Intervention: Semen samples from healthy volunteers and infertile patients
Number of subjects: 0
Study: 2167952

Group type: EXPERIMENTAL
Intervention: Hyperfractionated radiation therapy at 69.6 Gy
Number of subjects: 848

Group type: COMPARATOR
Intervention: Hyperfractionated radiation therapy at 60.0 to 64.8 Gy
Number of subjects: 848

Group type: COMPARATOR
Intervention: Hyperfractionated radiation therapy at 69.6 to 74.4 Gy
Number of subjects: 848

Group type: COMPARATOR
Intervention: Hyperfractionated radiation therapy at 79.2 Gy
Number of subjects: 848
Study: 6102504

Group type: EXPERIMENTAL
Intervention: Dehydroemetine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Triamcinolone
Number of subjects: 40
Study: 30516419

Group type: EXPERIMENTAL
Intervention: Acid-etched surface miniscrews
Number of subjects: 40

Group type: COMPARATOR
Intervention: Machined surface miniscrews
Number of subjects: 40
Study: 28628679

Group type: EXPERIMENTAL
Intervention: Ingenol mebutate (IngMeb) gel at concentrations of 0.018% and 0.027%, applied once daily for 2 or 3 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 0
Study: 26117164

Group type: EXPERIMENTAL
Intervention: Implicit emotion regulation intervention via psychotherapy (specific dosage and duration not mentioned)
Number of subjects: 0
Study: 23846502

Group type: EXPERIMENTAL
Intervention: Surgery
Number of subjects: 605
Study: 21616527

Group type: EXPERIMENTAL
Intervention: Terutroban (30 mg per day)
Number of subjects: 9562

Group type: COMPARATOR
Intervention: Aspirin (100 mg per day)
Number of subjects: 9562
Study: 19004549

Group type: EXPERIMENTAL
Intervention: Subcutaneous Botulinum toxin type A (BoNT/A) 22.5U
Number of subjects: 14

Group type: COMPARATOR
Intervention: Isotonic saline
Number of subjects: 14
Study: 17530942

Group type: EXPERIMENTAL
Intervention: T. terrestris (450 mg.d(‐1))
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: T. terrestris
Number of subjects: 22
Study: 15126543

Group type: EXPERIMENTAL
Intervention: Methyltestosterone (2.5 mg/d) plus esterified estrogens (1.25 mg/d)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Esterified estrogens alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Methyltestosterone plus esterified estrogens
Number of subjects: 0
Study: 15466635

Group type: EXPERIMENTAL
Intervention: Systemic heparin treatment throughout the procedure
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Air filters between the catheter and both the contrast medium syringe and the catheter flushing
Number of subjects: 150

Group type: COMPARATOR
Intervention: Conventional angiographic technique (Control group)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Transcranial Doppler sonography (Air filter group)
Number of subjects: 150
Study: 10519582

Group type: EXPERIMENTAL
Intervention: Diabetes (self-reported history of physician-diagnosed diabetes or glycosylated hemoglobin > 10%)
Number of subjects: 4631

Group type: EXPERIMENTAL
Intervention: Retinopathy in black/mixed population regardless of diabetes status
Number of subjects: 4631

Group type: EXPERIMENTAL
Intervention: Retinopathy in black and mixed participants with diabetes
Number of subjects: 4631

Group type: EXPERIMENTAL
Intervention: Clinically significant macular edema (CSME) in participants with diabetes
Number of subjects: 4631
Study: 7627280

Group type: EXPERIMENTAL
Intervention: Intracytoplasmic sperm injection (ICSI)
Number of subjects: 1488

Group type: EXPERIMENTAL
Intervention: MESA with ICSI
Number of subjects: 1488

Group type: COMPARATOR
Intervention: Control group (no sperm injection)
Number of subjects: 1488
Study: 2117858

Group type: EXPERIMENTAL
Intervention: Metrifonate (MT, 10 mg/kg body weight)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Praziquantel (PR, 40 mg/kg body weight)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 100
Study: 6795461

Group type: EXPERIMENTAL
Intervention: 3 doses of vaccine (20 micrograms per dose) at 0, 1 and 6 months
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 3 doses of vaccine (20 micrograms per dose) + 3 ml of HBIG with the first dose
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HBIG together with the first and second doses of vaccine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 31112623

Group type: EXPERIMENTAL
Intervention: Vilaprisan 2 mg
Number of subjects: 36
Study: 28064304

Group type: EXPERIMENTAL
Intervention: Ophthalmic artery branch retrograde intervention with urokinase (400,000 U) and papaverine (30 mg)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Superselective ophthalmic artery/selective carotid intervention with urokinase (400,000 U) and papaverine (30 mg)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both groups (A and B)
Number of subjects: 50
Study: 26602322

Group type: EXPERIMENTAL
Intervention: Carotid artery stenting (CAS)
Number of subjects: 828

Group type: COMPARATOR
Intervention: Aspirin and clopidogrel in combination prior to CAS
Number of subjects: 828

Group type: COMPARATOR
Intervention: Open-cell stent
Number of subjects: 828

Group type: EXPERIMENTAL
Intervention: Closed-cell stent
Number of subjects: 828

Group type: COMPARATOR
Intervention: Cerebral protection device (CPD) use
Number of subjects: 828

Group type: COMPARATOR
Intervention: Age (per 5 years)
Number of subjects: 828

Group type: COMPARATOR
Intervention: Right-sided procedure
Number of subjects: 828
Study: 24343389

Group type: EXPERIMENTAL
Intervention: Aquacel
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Mediskin I
Number of subjects: 67

Group type: COMPARATOR
Intervention: Allevyn
Number of subjects: 67
Study: 22579409

Group type: EXPERIMENTAL
Intervention: Noxious pressure stimulation
Number of subjects: 22

Group type: COMPARATOR
Intervention: Healthy controls, n=52
Number of subjects: 22
Study: 21119312

Group type: EXPERIMENTAL
Intervention: Corticosteroid injections (intra-articular or subacromial) with local anesthetic
Number of subjects: 38

Group type: COMPARATOR
Intervention: Transcutaneous electrical nerve stimulation and therapeutic exercise program
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Corticosteroid injections
Number of subjects: 38

Group type: COMPARATOR
Intervention: Brunnstrom upper-extremity score
Number of subjects: 38

Group type: COMPARATOR
Intervention: Modified Ashworth scale
Number of subjects: 38
Study: 17986403

Group type: EXPERIMENTAL
Intervention: MRI report seen by surgeons (intervention group)
Number of subjects: 252

Group type: COMPARATOR
Intervention: No MRI report seen by surgeons (control group)
Number of subjects: 252
Study: 16302384

Group type: EXPERIMENTAL
Intervention: Color category shared with distractors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Color category not shared with distractors
Number of subjects: 0
Study: 11987579

Group type: EXPERIMENTAL
Intervention: Vaccinated against influenza
Number of subjects: 375

Group type: COMPARATOR
Intervention: Non-vaccinated subjects
Number of subjects: 375

Group type: EXPERIMENTAL
Intervention: Vaccinated and non-vaccinated subjects
Number of subjects: 375
Study: 9609601

Group type: EXPERIMENTAL
Intervention: Educational efforts and promotion of information using various media
Number of subjects: 0
Study: 7702031

Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation
Number of subjects: 21906

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21906
Study: 31778719

Group type: EXPERIMENTAL
Intervention: Hormonal contraceptives (HCs)
Number of subjects: 395

Group type: COMPARATOR
Intervention: Naturally cycling women (NC)
Number of subjects: 395

Group type: EXPERIMENTAL
Intervention: Estradiol (among NC women)
Number of subjects: 395

Group type: EXPERIMENTAL
Intervention: Testosterone (among HC women)
Number of subjects: 395
Study: 31061017

Group type: EXPERIMENTAL
Intervention: liraglutide 3 mg/day
Number of subjects: 150

Group type: COMPARATOR
Intervention: liraglutide placebo 3 mg/day
Number of subjects: 150
Study: 29979699

Group type: EXPERIMENTAL
Intervention: I-HAES®
Number of subjects: 58

Group type: COMPARATOR
Intervention: CTRL
Number of subjects: 58
Study: 26790823

Group type: EXPERIMENTAL
Intervention: Clomethiazole treatment after 24 hours
Number of subjects: 30

Group type: COMPARATOR
Intervention: Acute alcohol withdrawal syndrome
Number of subjects: 30
Study: 24919813

Group type: EXPERIMENTAL
Intervention: Rasagiline 1 mg/d
Number of subjects: 321

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 321
Study: 22779218

Group type: EXPERIMENTAL
Intervention: Waterpik Complete Care (WFS)
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Sensonic Professional Plus Toothbrush (SPP)
Number of subjects: 139

Group type: COMPARATOR
Intervention: Sonicare FlexCare (SF)
Number of subjects: 139

Group type: COMPARATOR
Intervention: Oral-B Indicator manual toothbrush (MT)
Number of subjects: 139
Study: 19169140

Group type: EXPERIMENTAL
Intervention: Valacyclovir 500 mg twice daily
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 17982706

Group type: EXPERIMENTAL
Intervention: Meat-based diet
Number of subjects: 57

Group type: COMPARATOR
Intervention: Vegetable-based diet
Number of subjects: 57
Study: 15110806

Group type: EXPERIMENTAL
Intervention: Sentinel lymphadenectomy (SL) using technetium 99 m sulfur colloid
Number of subjects: 1094

Group type: EXPERIMENTAL
Intervention: Sentinel lymphadenectomy (SL) in node-negative patients
Number of subjects: 1094
Study: 11318256

Group type: EXPERIMENTAL
Intervention: Adolescents whose parents were unemployed
Number of subjects: 522

Group type: EXPERIMENTAL
Intervention: Adolescents living with two parents
Number of subjects: 522
Study: 9133695

Group type: EXPERIMENTAL
Intervention: Radioiodine treatment with a standard activity of 15 mCi (555 MBq) of 131I
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Target dose of 100 Gy
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Standard activity (15 mCi) with additional calculation of actual target dose
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Thyroid volume reduction
Number of subjects: 205
Study: 7898964

Group type: COMPARATOR
Intervention: Exosurf Neonatal (artificial surfactant)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Curosurf (natural porcine surfactant)
Number of subjects: 24
Study: 3307900

Group type: EXPERIMENTAL
Intervention: Intravenous lignocaine (2 mg/kg)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control (saline)
Number of subjects: 35
Study: 31868051

Group type: EXPERIMENTAL
Intervention: Forced Oscillation Technique (FOT)
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Body Plethysmography
Number of subjects: 154

Group type: COMPARATOR
Intervention: Control Group (Healthy Controls)
Number of subjects: 154
Study: 30113646

Group type: COMPARATOR
Intervention: Amino acid concentrations in South‐Asian Surinamese women
Number of subjects: 700

Group type: COMPARATOR
Intervention: Acylcarnitine and amino acid levels in South‐Asian Surinamese men
Number of subjects: 700

Group type: EXPERIMENTAL
Intervention: Metabolite levels
Number of subjects: 700

Group type: EXPERIMENTAL
Intervention: Results after adjustment for body mass index and intake of fat and total energy
Number of subjects: 700
Study: 26993629

Group type: EXPERIMENTAL
Intervention: Preventive cognitive therapy with gradual, guided discontinuation of SSRIs under medical management (STOP)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Continuation of SSRIs (GO)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Preventive cognitive therapy with gradual, guided discontinuation of SSRIs (STOP)
Number of subjects: 200
Study: 25825421

Group type: EXPERIMENTAL
Intervention: Botulinum toxin A (40 units into each pectoralis major muscle through 4 serial injections)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Botulinum toxin A
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (0.9% NaCl, 4 serial injections)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 23380314

Group type: EXPERIMENTAL
Intervention: l-5-hydroxytryptophan (l-5-HTP)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Fluoxetine
Number of subjects: 60
Study: 19952819

Group type: EXPERIMENTAL
Intervention: 20-min lower-body cold-water immersion
Number of subjects: 8

Group type: COMPARATOR
Intervention: No cooling intervention (control)
Number of subjects: 8
Study: 17869052

Group type: EXPERIMENTAL
Intervention: Interpersonal violence exposure
Number of subjects: 238

Group type: COMPARATOR
Intervention: No violence exposure
Number of subjects: 238
Study: 16169344

Group type: EXPERIMENTAL
Intervention: Rotational atherectomy (RA) followed by beta-radiation therapy
Number of subjects: 113

Group type: COMPARATOR
Intervention: Cutting balloon angioplasty (CBA) followed by beta-radiation therapy
Number of subjects: 113
Study: 12848680

Group type: EXPERIMENTAL
Intervention: Imagent (perflexane lipid microspheres) administered as an IV bolus at 0.125 mg/kg body weight
Number of subjects: 409

Group type: EXPERIMENTAL
Intervention: Imagent
Number of subjects: 409

Group type: COMPARATOR
Intervention: Noncontrast echocardiography
Number of subjects: 409
Study: 10534058

Group type: EXPERIMENTAL
Intervention: Cyclosporine, methotrexate, and prednisone (CSA/MTX/PSE)
Number of subjects: 149

Group type: COMPARATOR
Intervention: Cyclosporine and prednisone (CSA/PSE)
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Both regimens
Number of subjects: 149
Study: 15321322

Group type: EXPERIMENTAL
Intervention: Spinal anaesthesia with 2.0 ml hyperbaric 0.5% bupivacaine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Epidural anaesthesia with a local anaesthetic mixture (0.5% bupivacaine plain 10 ml, 2% lignocaine plain 10 ml, 0.1 ml of adrenaline 1 in 1000, and 2 ml of 8.4% sodium bicarbonate)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Spinal anaesthesia
Number of subjects: 40

Group type: COMPARATOR
Intervention: Epidural anaesthesia
Number of subjects: 40
Study: 1817663

Group type: EXPERIMENTAL
Intervention: Cantamega‐2000 (1 tablet daily at breakfast for 4 weeks)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Polivitaminizant S (2 tablets daily at breakfast for 4 weeks)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Cantamega‐2000
Number of subjects: 20
Study: 6812449

Group type: EXPERIMENTAL
Intervention: Flunisolide (F)
Number of subjects: 125
Study: 30663977

Group type: EXPERIMENTAL
Intervention: IBI305 (3 mg/kg)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Bevacizumab
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: IBI305
Number of subjects: 100
Study: 30136447

Group type: EXPERIMENTAL
Intervention: linaclotide 0.5 mg
Number of subjects: 500

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: linaclotide (after switching from placebo)
Number of subjects: 500
Study: 27737713

Group type: EXPERIMENTAL
Intervention: Self-management plan with a temporary quadrupling of the dose of inhaled corticosteroid (maximum of 14 days)
Number of subjects: 1800

Group type: COMPARATOR
Intervention: Self-management plan without an increase in inhaled corticosteroid
Number of subjects: 1800
Study: 24588434

Group type: EXPERIMENTAL
Intervention: Low-intensity CRRT (25 mL/kg/hour)
Number of subjects: 1441

Group type: COMPARATOR
Intervention: High-intensity CRRT (40 mL/kg/hour)
Number of subjects: 1441
Study: 21974692

Group type: EXPERIMENTAL
Intervention: Interdisciplinary prevention programme (IG)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Medically treated by local dermatologists (CG)
Number of subjects: 102
Study: 20090434

Group type: EXPERIMENTAL
Intervention: Scheduled dosing of acetaminophen and hydrocodone (167 mg/2.5 mg/5 mL) every 4 hours ATC (Groups B and C)
Number of subjects: 113

Group type: COMPARATOR
Intervention: PRN dosing of acetaminophen and hydrocodone every 4 hours (Group A)
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Scheduled dosing of acetaminophen and hydrocodone (167 mg/2.5 mg/5 mL)
Number of subjects: 113
Study: 17526976

Group type: EXPERIMENTAL
Intervention: Nicorandil (5 mg tid)
Number of subjects: 232

Group type: COMPARATOR
Intervention: Isosorbide mononitrate (ISMN: 20 mg bid)
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: Nicorandil and ISMN
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: Nicorandil
Number of subjects: 232
Study: 15476906

Group type: EXPERIMENTAL
Intervention: Valdecoxib 40 mg/d
Number of subjects: 293

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 293
Study: 11522870

Group type: EXPERIMENTAL
Intervention: BCAA supplementation (12 g/day)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 9760009

Group type: COMPARATOR
Intervention: Propranolol (40 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Captopril (25 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Verapamil (80 mg)
Number of subjects: 0
Study: 8156094

Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) therapy for 3 years
Number of subjects: 10
Study: 3045718

Group type: EXPERIMENTAL
Intervention: Single dose gentamicin therapy (n = 39)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Seven day course of an appropriate antibiotic (n = 30)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Single dose gentamicin therapy
Number of subjects: 69

Group type: COMPARATOR
Intervention: Seven day course of an appropriate antibiotic
Number of subjects: 69
Study: 31852385

Group type: EXPERIMENTAL
Intervention: Compassion meditation
Number of subjects: 74

Group type: COMPARATOR
Intervention: Mindfulness meditation
Number of subjects: 74

Group type: COMPARATOR
Intervention: Active control class
Number of subjects: 74

Group type: COMPARATOR
Intervention: No-class control
Number of subjects: 74
Study: 29766259

Group type: EXPERIMENTAL
Intervention: Telephone outcall program
Number of subjects: 108
Study: 27662042

Group type: EXPERIMENTAL
Intervention: Regular human insulin by jet injection (0.2 units/kg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Insulin aspart by conventional pen
Number of subjects: 20
Study: 24895108

Group type: EXPERIMENTAL
Intervention: Umeclidinium (UMEC) 62.5 mcg QD
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Umeclidinium (UMEC) 125 mcg QD
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Umeclidinium (UMEC) doses ≥62.5 mcg QD
Number of subjects: 2

Group type: COMPARATOR
Intervention: Umeclidinium (UMEC) BID dosing
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Umeclidinium (UMEC) QD dosing
Number of subjects: 2
Study: 23165811

Group type: COMPARATOR
Intervention: Normal group (hemoglobin concentration 12-15 g/dl), n=42
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Anemic group (hemoglobin concentration 7-10 g/dl), n=44
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Anemic group (hemoglobin concentration 7-10 g/dl)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 86
Study: 20977018

Group type: EXPERIMENTAL
Intervention: Mentors (fifth-year students)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mentees (fourth-year students)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (non-mentors)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (non-mentees)
Number of subjects: 0
Study: 18414916

Group type: EXPERIMENTAL
Intervention: 0.05 mg morphine
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 0.1 mg morphine
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 0.2 mg morphine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 15740945

Group type: EXPERIMENTAL
Intervention: Redivac drains
Number of subjects: 546

Group type: COMPARATOR
Intervention: Conventional underwater-seal drains
Number of subjects: 546
Study: 12433017

Group type: EXPERIMENTAL
Intervention: Action letters (messages providing information on where and when to receive a flu shot)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No letters (no messages)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Reminder letters (messages intended to increase flu immunizations)
Number of subjects: 0